Ablaze Pharmaceuticals
A medical method that delivers radionuclides to tumor cells through targeted molecules to precisely kill cancer cells at close range, so as to achieve therapeutic purposes.
Employees
Enterprise value
$300—450m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $75.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads